NORGES BANK - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$1,273,000
+2.0%
352,6120.0%0.00%0.0%
Q4 2016$1,248,000
-8.3%
352,6120.0%0.00%0.0%
Q3 2016$1,361,000
-27.5%
352,612
-17.5%
0.00%0.0%
Q2 2016$1,877,000
+16.2%
427,6120.0%0.00%0.0%
Q1 2016$1,616,000
-82.8%
427,612
-28.5%
0.00%
-80.0%
Q4 2015$9,378,000
+33.4%
598,115
-10.3%
0.01%
+25.0%
Q3 2015$7,032,000
-58.2%
667,1280.0%0.00%
-50.0%
Q2 2015$16,825,000
+28.0%
667,128
+41.5%
0.01%
+33.3%
Q1 2015$13,143,000
+52.7%
471,5650.0%0.01%
+50.0%
Q4 2014$8,606,000
+26.1%
471,565
-10.4%
0.00%0.0%
Q3 2014$6,824,000
-68.3%
526,540
-60.0%
0.00%
-33.3%
Q2 2014$21,502,0001,317,5040.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders